Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioNTech SE - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
BNTX
Nasdaq
2836
www.biontech.de
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioNTech SE
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
- May 30th, 2026 12:15 pm
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week
- May 29th, 2026 9:11 am
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
- May 28th, 2026 9:14 am
BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says
- May 27th, 2026 11:42 am
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
- May 27th, 2026 9:08 am
This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative.
- May 27th, 2026 9:07 am
BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting
- May 22nd, 2026 3:00 am
BioNTech (NasdaqGS:BNTX) Valuation After New Supervisory Board Appointments Focused On Oncology And Commercial Expertise
- May 20th, 2026 9:20 pm
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
- May 20th, 2026 1:29 pm
BioNTech Expands Supervisory Board To Support Oncology Pipeline And Commercial Plans
- May 20th, 2026 9:17 am
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
- May 18th, 2026 9:11 am
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
- May 15th, 2026 2:15 pm
BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM
- May 15th, 2026 10:10 am
BioNTech Announces New ADS Repurchase Program
- May 7th, 2026 4:45 am
BioNTech Expands Oncology Trials And Reshapes Manufacturing As Investors Weigh Upside
- May 6th, 2026 5:12 am
BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls.
- May 5th, 2026 12:12 pm
European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
- May 5th, 2026 9:08 am
BioNTech Q1 Earnings Call Highlights
- May 5th, 2026 8:14 am
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
- May 5th, 2026 4:45 am
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
- May 1st, 2026 9:10 am
Scroll